Company Analysis

Praxis Precision Medicines, Inc. (PRAX)

Nasdaq: PRAX · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2016
Grade4.8
◀ Past 3.0● Present 6.1▶ Future 4.6
4 est.

Who runs Praxis Precision Medicines, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Souza Marcio
Chief Executive Officer. First filing Oct 2020, latest Jul 8, 2026, 5 filings in all.
Officers reporting now
5
of 13 people with a filing in the last fifteen months
Directors reporting now
8
19 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Souza MarcioChief Executive OfficerOct 2020Jul 8, 2026none
Kelly Timothy EdwinChief Financial OfficerMay 2021May 19, 2026none
Sniecinski MeganChief Operating OfficerJan 2026May 19, 2026none
Mastrocola LaurenPrincipal Accounting OfficerOct 2020May 19, 20262 · $2.6M
Nemiroff AlexGeneral Counsel and SecretaryOct 2020May 19, 20264 · $4.9M
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Desimone JilldirectorMay 2022Jun 26, 202612 · $3.6M
Arbuckle Stuart AdirectorJan 2026Jun 12, 2026none
Chodakewitz JeffreydirectorApr 2021Jun 12, 2026none
Cudkowicz Merit EsterdirectorApr 2021Jun 12, 2026none
Kindler Jeffrey BdirectorJan 2026Jun 12, 2026none
Mitchell Dean JdirectorOct 2020Jun 12, 2026none
Norden GregorydirectorOct 2020Jun 12, 2026none
Young William DdirectorOct 2020Jun 12, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Adage Capital Management, L.P.10% ownerAug 2025Oct 17, 2025none
Atchinson Robert10% ownerAug 2025Oct 17, 2025none
Gross Phillip10% ownerAug 2025Oct 17, 202510 · $33.2M
Earlier names on the record19, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PRAX · research, not advice